跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
!!Link opens in a new tab
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
Solanum nigrum protects against hepatic fibrosis via suppression of hyperglycemia in high-fat/ethanol diet-induced rats
Cheng Jeng Tai
, Chen Yen Choong
, Yeu Ching Shi
, Yu Chun Lin
, Chia-Woei Wang
, Bao Hong Lee
, Chen Jei Tai
血液腫瘤科
臺北醫學大學附設醫院
婦產學科
中草藥臨床藥物研發博士學位學程
生藥學研究所
臨床醫學研究所
研究成果
:
雜誌貢獻
›
文章
›
同行評審
24
!!Link opens in a new tab
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Solanum nigrum protects against hepatic fibrosis via suppression of hyperglycemia in high-fat/ethanol diet-induced rats」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Hyperglycemia
100%
Alcohol
100%
Solanum
100%
Liver Fibrosis
100%
Lipid Diet
87%
Peroxisome Proliferator Activated Receptor
25%
Advanced Glycation End-Product
25%
Oral Drug Administration
25%
Hyperlipidemia
12%
Advanced Glycation End Product Receptor
12%
Insulin Resistance
12%
Receptor
12%
Smooth Muscle Actin
12%
Absence
12%
Protein Binding
12%
Liver Disease
12%
Gelatinase A
12%
DNA Responsive Element
12%
Hyperinsulinemia
12%
Acetyl-CoA
12%
Carboxylase
12%
Hepatic Stellate Cell
12%
Fatty Acid Synthase
12%
Pioglitazone
12%
Lipogenesis
12%
Biochemistry, Genetics and Molecular Biology
Hyperglycemia
100%
Solanum Nigrum
100%
Extract
85%
Advanced Glycation End-Product
42%
Eicosanoid Receptor
28%
Peroxisome Proliferator-Activated Receptor
28%
Animal Model
14%
Hyperlipidemia
14%
Response Element
14%
Messenger RNA
14%
Binding Protein
14%
Wistar Rat
14%
Hepatic Stellate Cell
14%
Lipogenesis
14%
Acetyl-CoA Carboxylase
14%
Pioglitazone
14%
Actin
14%
Insulin Resistance
14%
Gelatinase A
14%
MMP2
14%
Fatty Acid Synthase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Fibrosis
100%
Solanum Nigrum
100%
Hyperglycemia
100%
Advanced Glycation End Product
28%
Peroxisome Proliferator Activated Receptor
28%
Hyperlipidemia
14%
Receptor
14%
Absence
14%
Wistar Rat
14%
Binding Protein
14%
Liver Disease
14%
Gelatinase A
14%
Advanced Glycation End Product Receptor
14%
Smooth Muscle Actin
14%
Fatty Acid Synthase
14%
Carboxylase
14%
Acetyl-CoA
14%
Pioglitazone
14%
Hyperinsulinemia
14%
Insulin Resistance
14%